PET / CT of pulmonary perfusion with Gallium68 for the preservation of pulmonary function during pulmonary stereotaxic radiotherapy.
Phase 1
- Conditions
- on-small cell lung cancer (NSCLC) or lung metastasesMedDRA version: 20.0Level: SOCClassification code 10038738Term: Respiratory, thoracic and mediastinal disordersSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disordersTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Registration Number
- EUCTR2021-002224-20-FR
- Lead Sponsor
- CHRU de Brest
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients d'âge supérieur à 18 ans, assuré social, traité par SBRT pour une lésion primitive ou secondaire au CHRU de Brest.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 60
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 60
Exclusion Criteria
1) Incapacité/refus de donner son consentement
2) Femmes enceintes ou allaitant
3) Patient sous tutelle ou curatelle
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method